Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06379061 · ClinicalTrials.gov registry record
Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts
A clinical trial, sponsored by Beckman Coulter.
- Completed
- Registry status
- 650
- Enrollment target
NCT06379061 is a clinical trial that has completed, run by Beckman Coulter. The registered enrollment target is 650 participants.
The verdict
NCT06379061 has completed, sponsored by Beckman Coulter.
- COMPLETED
- Registry status
- 650 participants
- Enrollment target
Study Summary
The purpose of the pivotal study is to collect blood specimens and clinical data from pediatric (\>90 days old) and adult (≥18 years old) patients presenting with signs and symptoms suggestive of acute bacterial or viral infection. These samples will be used to establish the diagnostic performance of MeMed BV™ for differentiating bacterial from viral infection using method comparison and/or method concordance.
Interventions
- OTHER Adult and Pediatrics
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 650 participants |
| Start Date | 2024-06-12 |
| Est. Completion | 2025-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06379061
The ClinicalTrials.gov registry entry for NCT06379061 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 650 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beckman Coulter, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Adult and Pediatrics is the first listed.
NCT06379061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06379061 about?
NCT06379061 is a clinical study titled "Access MeMed BV Assay Clinical Study Collection Protocol - Infectious Adult and Pediatric Cohorts". The purpose of the pivotal study is to collect blood specimens and clinical data from pediatric (\>90 days old) and adult (≥18 years old) patients presenting with signs and symptoms suggestive of acute bacterial or viral infection. These samples will be used to establish the diagnostic performance o...
What is the current status of trial NCT06379061?
This trial is currently completed. The enrollment target is 650 participants. The study started on 2024-06-12. Estimated completion is 2025-04-30.
What interventions are being tested in trial NCT06379061?
The interventions under investigation include: Adult and Pediatrics (OTHER).
Who is sponsoring clinical trial NCT06379061?
This trial is sponsored by Beckman Coulter, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.